Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease | Patent Number 11744816

US 11744816 B2
Application Number17136870
Publication NumberUS 20210361605 A1
Pendency2 years, 8 months, 10 days
Filled DateDec 29, 2020
Priority DateMar 13, 2015
Publication DateNov 25, 2021
Expiration DateMar 12, 2035
Inventor/ApplicantsNoah Rosenberg
Roger Schofield Newton
Diane Elaine MacDougall
Noah Laban Rosenberg
ExaminesKANTAMNENI, SHOBHA
Art Unit1627
Technology Center1600
Assignments
Esperion Therapeutics Inc.
Current
Esperion Therapeutics Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.